Payload diversification: a key step in the development of antibody-drug conjugates von Conilh, Louise, Sadilkova, Lenka, Viricel, Warren, Dumontet, Charles

Volltext

Exatecan Antibody Drug Conjugates Based on a Hydrophilic Polysarcosine Drug-Linker Platform von Conilh, Louise, Fournet, Guy, Fourmaux, Eric, Murcia, Angelique, Matera, Eva-Laure, Joseph, Benoit, Dumontet, Charles, Viricel, Warren

Volltext

Characterization of T‐DM1‐resistant breast cancer cells von Sauveur, Juliette, Conilh, Louise, Beaumel, Sabine, Chettab, Kamel, Jordheim, Lars‐Petter, Matera, Eva‐Laure, Dumontet, Charles

Volltext

The first ADC bearing the ferroptosis inducer RSL3 as a payload with conservation of the fragile electrophilic warhead von Nguyen, Kim-Anh, Conilh, Louise, Falson, Pierre, Dumontet, Charles, Boumendjel, Ahcène

Volltext

Abstract 1544: MBK-103, a potent novel conjugation platform-based antibody-drug conjugate, changing therapeutic options in folate receptor alpha positive cancer patients von Viricel, Warren, Conilh, Louise, Leroy, Edouard, Lafay, Jean-Guillaume, Brune, Frederique, Sadilkova, Lenka Kyrych, Dumontet, Charles

Volltext

Abstract 1779: Inability to regulate ROS content confers sensitivity to ferroptosis in breast cancer cells resistant to T-DM1 von Conilh, Louise, Sauveur, Juliette, Beaumel, Sabine, Scheffges, Claire, Nunez, Estelle, Cheillan, David, Dumontet, Charles

Volltext